Menopause and ADHD:
why symptoms can suddenly feel harder.

One of the things I increasingly hear from women with ADHD is something along the lines of: “I used to cope. Why does everything suddenly feel so much harder?”

Often this happens in their 40s. They may describe worsening concentration, forgetfulness, irritability, feeling overwhelmed, losing things, struggling to organise themselves, or simply finding that the strategies which have kept everything together for years no longer seem to work.

Sometimes this leads to a diagnosis of ADHD for the first time. In women who already know they have ADHD, it can feel as though their ADHD has suddenly become significantly worse.

There is increasing interest in one possible contributor to this: perimenopause and the changing effect of oestrogen on the brain.

ADHD isn’t just about dopamine — but dopamine matters

ADHD is considerably more complicated than simply having “too little dopamine”. However, dopamine and noradrenaline are important neurotransmitters in brain networks involved in attention, motivation, working memory and executive function. These are also the systems targeted by many ADHD medications.

Oestrogen interacts with these neurotransmitter systems. Experimental and preclinical evidence suggests that oestrogen can influence dopamine production, receptors, reuptake and breakdown, including in areas such as the prefrontal cortex and basal ganglia — regions which are important in ADHD.

Changing oestrogen → changing dopamine signalling → potentially changing ADHD symptoms.

It is important to emphasise the word potentially. The biology is much more complicated than “oestrogen goes down, therefore dopamine goes down”. But it gives us a plausible reason why hormonal changes might matter in ADHD.

Perimenopause isn’t simply a gradual fall in oestrogen

During perimenopause, hormone levels do not necessarily decline smoothly. They can fluctuate considerably. That may help explain why women sometimes describe their cognitive symptoms as unpredictable.

One week they feel reasonably organised. The next they cannot remember why they walked into a room, have six unfinished jobs on the go and feel disproportionately irritated because someone has asked where the car keys are.

Some of this can, of course, happen during menopause without ADHD. Sleep disturbance, hot flushes, anxiety and low mood can all impair concentration and memory. But there is an interesting overlap with ADHD.

The symptoms overlap enormously

Common complaints during perimenopause include:

• forgetfulness and “brain fog”
• difficulty concentrating
• poorer working memory
• sleep disturbance
• irritability and emotional lability
• feeling overwhelmed
• anxiety or low mood

That list can sound remarkably familiar to someone with ADHD. A 2026 narrative review examining ADHD during perimenopause and menopause described worsening inattention and emotional dysregulation alongside anxiety, depression, sleep problems and cognitive complaints.

This creates an interesting clinical problem. Is this menopause? Is this ADHD? Or is it both?

Increasingly, I think the third possibility deserves consideration.

Why might ADHD first become obvious at this point?

This is particularly interesting in women who receive an ADHD diagnosis in their 40s or 50s.

ADHD does not suddenly develop during menopause. It is a neurodevelopmental condition, so when assessing somebody for ADHD we would still expect evidence that the underlying traits were present much earlier in life.

But somebody can have ADHD traits for decades without recognising them as ADHD. They may have been bright academically. They may have developed elaborate organisational systems. They may have chosen jobs which suit the way their brain works. They may have relied on anxiety, deadlines or sheer effort to keep themselves organised.

And many women with predominantly inattentive ADHD were simply missed when they were children.

Then something changes. Children become more demanding. Careers become more complicated. Elderly parents need help. Sleep deteriorates. Hormones begin fluctuating. At the same time, the brain chemistry which may previously have helped compensate for ADHD is changing.

Suddenly the scaffolding starts wobbling. The ADHD hasn’t appeared from nowhere. The ability to compensate for it may have changed.

We see hints of this earlier in life too

One reason the menopause hypothesis is interesting is that menopause is not the only time women report changes in ADHD symptoms.

A 2025 systematic review examined evidence linking female sex hormones and ADHD. It found suggestive evidence that ADHD symptoms can vary with hormonal changes, particularly during puberty and across the menstrual cycle. Some studies reported worsening inattention, executive dysfunction, irritability and other symptoms during phases associated with lower or falling oestrogen.

That does not prove that menopause worsens ADHD. The review included only 11 studies, many small and methodologically quite different, and highlighted menopause as an area requiring much more research. But biologically and clinically, the pieces are beginning to fit together.

What about ADHD medication?

Some women report that medication which previously worked well seems less effective at certain points in their menstrual cycle or during perimenopause. There is some early evidence supporting changes in perceived medication effectiveness across hormonal phases, but again the research is limited.

The 2026 review of ADHD treatment during menopause makes the evidence gap particularly clear: there are currently no randomised controlled trials specifically examining ADHD medication in perimenopausal or menopausal women.

That is quite remarkable when you consider how many women are affected by both ADHD and menopause.

For now, treatment therefore needs to be individualised rather than assuming that there is a standard “menopause ADHD dose”. If somebody taking ADHD medication notices a significant change in symptoms during perimenopause, it is reasonable to review the whole picture: medication duration and effectiveness, sleep, mood, cardiovascular health, menopausal symptoms and other causes of cognitive difficulty.

Does HRT treat ADHD?

This is where we need to be particularly careful.

There is a biologically plausible argument that menopausal hormone therapy might influence some of the cognitive or emotional difficulties experienced by women with ADHD. But that is not the same as saying that HRT is a treatment for ADHD.

At present we simply do not have good trials showing that starting HRT improves core ADHD symptoms or makes stimulant medication work better. HRT may, of course, be appropriate for menopausal symptoms in its own right. Improving hot flushes, sleep and mood may also make concentration and day-to-day functioning considerably better.

The 2026 review discusses menopausal hormone therapy as a potentially useful adjunct but concludes that its effect specifically on ADHD treatment outcomes has not yet been formally evaluated. So this is an interesting area of medicine, rather than a reason to prescribe HRT solely for ADHD.

Perhaps the most important point

For many years, ADHD research was disproportionately based on boys and men. We are now recognising that ADHD can look different in girls and women, and that the hormonal environment across a woman’s life may influence how symptoms are experienced. A recent review of female ADHD describes puberty, menstrual cycles, pregnancy and perimenopause as important areas where we still need much better research.

For a woman in her 40s saying, “I’ve always been a bit like this, but recently I just can’t cope in the way I used to,” it is worth thinking beyond a single diagnosis.

She may be experiencing perimenopause. She may have previously unrecognised ADHD. She may have both.

And the interaction between the two may turn out to be much more important than medicine has traditionally appreciated.

The science is not settled yet. But it is an area where the research is finally beginning to catch up with what many women have been describing for years.